1. Home
  2. PBYI vs HPH Comparison

PBYI vs HPH Comparison

Compare PBYI & HPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • HPH
  • Stock Information
  • Founded
  • PBYI 2010
  • HPH 2010
  • Country
  • PBYI United States
  • HPH China
  • Employees
  • PBYI N/A
  • HPH N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • HPH
  • Sector
  • PBYI Health Care
  • HPH
  • Exchange
  • PBYI Nasdaq
  • HPH NYSE
  • Market Cap
  • PBYI 153.2M
  • HPH 137.1M
  • IPO Year
  • PBYI N/A
  • HPH 2019
  • Fundamental
  • Price
  • PBYI $2.92
  • HPH $0.27
  • Analyst Decision
  • PBYI Strong Buy
  • HPH
  • Analyst Count
  • PBYI 1
  • HPH 0
  • Target Price
  • PBYI $7.00
  • HPH N/A
  • AVG Volume (30 Days)
  • PBYI 416.5K
  • HPH 86.6K
  • Earning Date
  • PBYI 11-07-2024
  • HPH 01-01-0001
  • Dividend Yield
  • PBYI N/A
  • HPH N/A
  • EPS Growth
  • PBYI 492.79
  • HPH N/A
  • EPS
  • PBYI 0.47
  • HPH N/A
  • Revenue
  • PBYI $243,569,000.00
  • HPH $286,996,105.00
  • Revenue This Year
  • PBYI N/A
  • HPH N/A
  • Revenue Next Year
  • PBYI N/A
  • HPH N/A
  • P/E Ratio
  • PBYI $6.26
  • HPH N/A
  • Revenue Growth
  • PBYI 6.30
  • HPH 1722.42
  • 52 Week Low
  • PBYI $2.23
  • HPH $0.26
  • 52 Week High
  • PBYI $7.73
  • HPH $10.06
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 47.45
  • HPH 29.69
  • Support Level
  • PBYI $2.82
  • HPH $0.28
  • Resistance Level
  • PBYI $3.12
  • HPH $0.37
  • Average True Range (ATR)
  • PBYI 0.20
  • HPH 0.03
  • MACD
  • PBYI -0.03
  • HPH 0.01
  • Stochastic Oscillator
  • PBYI 14.71
  • HPH 10.78

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About HPH HIGHEST PERFORMANCE HLDGS INC

Highest Performances Holdings Inc is a financial technology service group based on family financial asset allocation. It focuses on providing personalized wealth management services for emerging middle-class and affluent families, comprehensive support services for financial planners, and diversified financial services for institutional clients.

Share on Social Networks: